Curdlan-Induced Significant Enhancement of Lipid Oxidation Control and Gelling Properties of Low-Salt Marine Surimi Gel Containing Transglutaminase and Lysine
Gels · 10.07.2025 · 11 (7) · 535
DOI: 10.3390/gels11070535 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gels, online erschienen am 10.07.2025. Verfasst von Wenhui Ma und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medicine, Hubei University of Medicine, Shiyan 442000, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Key Industry Innovation Chain of Shaanxi (clusters)-Agriculture field, Wellcome Trust, the "Scientists+Engineers" Talent Team Construction Project of Shaanxi Province.
Abstract (Originalsprache)
In this study, curdlan was investigated as a substitute for egg-white protein, and the effects of different concentrations (0.2%, 0.4%, 0.6%, 0.8%, and 1.0%) on lipid oxidation and the physicochemical properties of a novel low-salt surimi gel containing transglutaminase (TGase) and lysine were evaluated. The results indicated that adding appropriate curdlan concentrations (0.2%–0.4%, especially 0.4%) significantly inhibited lipid oxidation in the surimi gel, achieving the highest L* and whiteness values. The fracture strength, WHC, hardness, and chewiness of the gel increased by 23.87%, 6.70%, 32.80%, and 13.49%, respectively, compared to the control gel containing egg-white protein (p < 0.05). At 0.4% curdlan, the gel also enhanced the crosslinking within the surimi, improved its resistance to shear stress, significantly increased the G’ value, and shortened the T21, T22, and T23 relaxation times, inhibiting the conversion of immobilized to free water in the gel and promoting a denser three-dimensional network structure. However, excessive curdlan amounts (0.6%–1.0%) led to a notable deterioration in the gel performance, causing a more irregular microstructure, the formation of larger cluster-like aggregates, and a negative effect on color. In conclusion, the combination of 0.4% curdlan with TGase and Lys is effective for preparing low-salt surimi products.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Basic Medicine, Hubei University of Medicine, Shiyan 442000, China.
- Natural Food Macromolecule Research Center, School of Food Science and Engineering, Shaanxi University of Science and Technology, Xi'an 710021, China.
- Linyi Jinluo Win Ray Food Co., Ltd., Linyi 276036, China.
Förderung
- the Key Industry Innovation Chain of Shaanxi (clusters)-Agriculture field
- Wellcome Trust
- the "Scientists+Engineers" Talent Team Construction Project of Shaanxi Province
- the Shaanxi Provincial Department of Education Scientific Research Program
- the Natural Science Foundation of Hubei Province of China
- the Faculty Development Grants from Hubei University of Medicine
- Key Industry Innovation Chain of Shaanxi (clusters)-Agriculture field
- Science and Technology Innovation Development Plan Project of Linyi Lanshan District
Zitieren
APA
Ma, W., Liang, G., Huang, Q., Ling, F., Pan, W., Cao, Y., & Chen, M. (2025). Curdlan-Induced Significant Enhancement of Lipid Oxidation Control and Gelling Properties of Low-Salt Marine Surimi Gel Containing Transglutaminase and Lysine. Gels, 11(7), 535. https://doi.org/10.3390/gels11070535
Vancouver
Ma W, Liang G, Huang Q, Ling F, Pan W, Cao Y, et al. Curdlan-Induced Significant Enhancement of Lipid Oxidation Control and Gelling Properties of Low-Salt Marine Surimi Gel Containing Transglutaminase and Lysine. Gels. 2025;11(7):535. doi:10.3390/gels11070535
BibTeX
@article{Ma2025,
author = {Ma, Wenhui and Liang, Guangcan and Huang, Qiliang and Ling, Feng and Pan, Weilin and Cao, Yungang and Chen, Miao},
title = {Curdlan-Induced Significant Enhancement of Lipid Oxidation Control and Gelling Properties of Low-Salt Marine Surimi Gel Containing Transglutaminase and Lysine},
journal = {Gels},
year = {2025},
volume = {11},
number = {7},
pages = {535},
doi = {10.3390/gels11070535}
}
EUVIMED